PE20001598A1 - DERIVATIVES OF N- [2- (4-AMINOPHENIL) ETHYL] -2,3-DIHYDRO-1,4-BENZODIOXIN-2-METANAMINA - Google Patents
DERIVATIVES OF N- [2- (4-AMINOPHENIL) ETHYL] -2,3-DIHYDRO-1,4-BENZODIOXIN-2-METANAMINAInfo
- Publication number
- PE20001598A1 PE20001598A1 PE2000000275A PE0002752000A PE20001598A1 PE 20001598 A1 PE20001598 A1 PE 20001598A1 PE 2000000275 A PE2000000275 A PE 2000000275A PE 0002752000 A PE0002752000 A PE 0002752000A PE 20001598 A1 PE20001598 A1 PE 20001598A1
- Authority
- PE
- Peru
- Prior art keywords
- benzodioxin
- dihydro
- derivatives
- ethyl
- alcoxycarbonylmethyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
- C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
- C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D319/20—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring with substituents attached to the hetero ring
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
SE REFIERE A DERIVADOS DE N-[2-(4-AMINOFENIL)ETIL]-2,3-DIHIDRO-1,4-BENZODIOXIN-2-METANAMINA DE FORMULA I, DONDE: X ES H, HALOGENO, CIANO, NITRO, OH, ALQUILO C1-C4, FENILO, TIENILO, TIENILMETOXI, ALCOXI C1-C4, CICLOALQUILMETOXI C3-C6, FENILMETOXI, ALCOXICARBONILO C1-C4, ALCOXICARBONILMETILO C1-C4, PIRROLIDIN-1-ILCARBONILO, CARBAMOILO, ENTRE OTROS; R1 ES H, METILO; R2 ES ALCANOILO C1-C4, FENILALCANOILO C1-C4, METOXIACETILO, CICLOALQUILCARBONILO C3-C6, BENZOILO OPCIONALMENTE SUSTITUIDO CON HALOGENO, ALQUILO C1-C4, ALCOXI C1-C4, ENTRE OTROS; NR1R2 ES 2-OXO-4,5-DIHIDROOXAZOLIDIN-3-ILO. LOS COMPUESTOS DE FORMULA I TIENEN AFINIDAD POR LOS RECEPTORES DOPAMINERGICOS DE TIPO D3, AFINIDAD MODERADA DE TIPO D2 Y 5-HT1A Y PUEDEN SER UTILES PARA EL TRATAMIENTO DE PSICOSIS, ESQUIZOFRENIA, ANSIEDAD, PANICO, FOBIAS, TRASTORNOS OBSESIVO COMPULSIVOSREFERS TO DERIVATIVES OF N- [2- (4-AMINOPHENYL) ETHYL] -2,3-DIHYDRO-1,4-BENZODIOXIN-2-METHANAMINE OF FORMULA I, WHERE: X IS H, HALOGEN, CYANE, NITRO, OH , C1-C4 ALKYL, PHENYL, THENYL, THYENYLMETOXY, C1-C4 ALCOXY, C3-C6 CYCLOALKYLMETOXY, PHENYLMETOXY, C1-C4 ALCOXYCARBONYL, 1-CARBONYL ALCOXYCARBONYLMETHYL-ILCHRONYL, C1-C4 CARBONYL-1-PYRAMYL-ILCOXYCARBONYL, C1-C4, ALCOXYCARBONYLMETHYL-ILCHYL-C4 R1 IS H, METHYL; R2 IS C1-C4 ALKANOYL, C1-C4 PHENYLALKANOYL, METOXYACETYL, C3-C6 CYCLOALKYLCARBONYL, BENZOYL OPTIONALLY SUBSTITUTED WITH HALOGEN, C1-C4 ALKYL, C1-C4 ALCOXY, AMONG OTHERS; NR1R2 IS 2-OXO-4,5-DIHYDROOXAZOLIDIN-3-ILO. THE COMPOUNDS OF FORMULA I HAVE AFFINITY FOR TYPE D3 DOPAMINERGIC RECEPTORS, MODERATE AFFINITY OF TYPE D2 AND 5-HT1A AND MAY BE USEFUL FOR THE TREATMENT OF PSYCHOSIS, SCHIZOPHRENIA, ANXIETY, PANIC, PHOBOSIVE, OBSESSIVE DISORDERS
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9903936A FR2791675B1 (en) | 1999-03-30 | 1999-03-30 | DERIVATIVES OF N- [2- (4-AMINOPHENYL) ETHYL] -2,3-DIHYDRO-1,4- BENZODIOXINNE-2-METHANAMINE, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20001598A1 true PE20001598A1 (en) | 2001-04-01 |
Family
ID=9543788
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2000000275A PE20001598A1 (en) | 1999-03-30 | 2000-03-30 | DERIVATIVES OF N- [2- (4-AMINOPHENIL) ETHYL] -2,3-DIHYDRO-1,4-BENZODIOXIN-2-METANAMINA |
Country Status (6)
Country | Link |
---|---|
AU (1) | AU3660700A (en) |
CO (1) | CO5170535A1 (en) |
FR (1) | FR2791675B1 (en) |
PE (1) | PE20001598A1 (en) |
UY (1) | UY26085A1 (en) |
WO (1) | WO2000058301A1 (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0117396D0 (en) | 2001-07-17 | 2001-09-05 | Glaxo Group Ltd | Chemical compounds |
GB0308208D0 (en) | 2003-04-09 | 2003-05-14 | Glaxo Group Ltd | Chemical compounds |
WO2006089053A2 (en) | 2005-02-17 | 2006-08-24 | Wyeth | Cycloalkylfused indole, benzothiophene, benzofuran and indene derivatives |
AR056320A1 (en) | 2005-04-22 | 2007-10-03 | Wyeth Corp | CHROMAN AND CHROME DERIVATIVES, OBTAINING PROCESSES, PHARMACEUTICAL COMPOSITIONS AND USES OF THE SAME |
JP2008538575A (en) * | 2005-04-22 | 2008-10-30 | ワイス | Benzodioxane and benzodioxolane derivatives and their use |
AR060493A1 (en) * | 2006-04-18 | 2008-06-18 | Wyeth Corp | DERIVATIVES OF BENZODIOXAN AND BENZODIOXOLAN. OBTAINING PROCESSES. |
AR063373A1 (en) * | 2006-10-24 | 2009-01-21 | Wyeth Corp | DERIVATIVES OF BENZODIOXAN AND ITS USES |
JP5548853B2 (en) | 2008-04-29 | 2014-07-16 | インテグレイティブ・リサーチ・ラボラトリーズ・スウェーデン・アーベー | Modulator of dopamine neurotransmission |
AU2009242092A1 (en) | 2008-04-29 | 2009-11-05 | Nsab, Filial Af Neurosearch Sweden Ab, Sverige | Modulators of dopamine neurotransmission |
JP2011519839A (en) * | 2008-04-29 | 2011-07-14 | エヌエスエイビー、フィリアル アヴ ノイロサーチ スウェーデン エービー、スヴェーリエ | Modulator of dopamine neurotransmission |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL281245A (en) * | 1962-07-20 | |||
CA1147342A (en) * | 1977-10-12 | 1983-05-31 | Kazuo Imai | Process of producing novel phenylethanolamine derivatives |
-
1999
- 1999-03-30 FR FR9903936A patent/FR2791675B1/en not_active Expired - Fee Related
-
2000
- 2000-03-27 AU AU36607/00A patent/AU3660700A/en not_active Abandoned
- 2000-03-27 WO PCT/FR2000/000762 patent/WO2000058301A1/en active Application Filing
- 2000-03-29 CO CO00022433A patent/CO5170535A1/en not_active Application Discontinuation
- 2000-03-29 UY UY26085A patent/UY26085A1/en unknown
- 2000-03-30 PE PE2000000275A patent/PE20001598A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
UY26085A1 (en) | 2000-10-31 |
WO2000058301A1 (en) | 2000-10-05 |
AU3660700A (en) | 2000-10-16 |
CO5170535A1 (en) | 2002-06-27 |
FR2791675B1 (en) | 2001-05-04 |
FR2791675A1 (en) | 2000-10-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PE68799A1 (en) | TETRAHYDROISOKINOLINE DERIVATIVES AS DOPAMINE D3 RECEPTOR MODULATORS | |
PE20001598A1 (en) | DERIVATIVES OF N- [2- (4-AMINOPHENIL) ETHYL] -2,3-DIHYDRO-1,4-BENZODIOXIN-2-METANAMINA | |
PE20040600A1 (en) | TRIAZOLE DERIVATIVES AS ANTAGONISTS OF THE TACHYCININ RECEPTOR | |
PE20061127A1 (en) | PROPANOSULPHONAMIDE DERIVATIVES THAT ENHANCE THE GLUTAMATE RECEPTOR | |
PE20031011A1 (en) | DERIVATIVES OF DIHIDROBENZODIAZEPIN-2-ONA-III | |
PE20010543A1 (en) | PURINE DERIVATIVES AS TYROSINCINASE SYK INHIBITORS | |
BR0214455A (en) | Benzothiazole Derivatives | |
PE20001483A1 (en) | OXAMIC ACIDS AND DERIVATIVES AS LIGANDS OF THYROID RECEPTORS | |
PE20011114A1 (en) | DECAHYDRO-ISOQUINOLINS | |
AR054021A1 (en) | CYCLOPENTAPIRIDINE AND TETRAHYDROQUINOLINE DERIVATIVES | |
ES2064973T3 (en) | NEW DERIVATIVES OF INDOL. | |
PE20040935A1 (en) | 2-QUINAZOLINE SUBSTITUTE-4-ILAMINE ANALOGS AS MODULATORS OF CAPSAICIN RECEPTORS | |
PE20061163A1 (en) | SUBSTITUTE N-SULFONYLAMINOPHENYLETHYL-2-PHENOXYACETAMIDE COMPOUNDS | |
PE20050145A1 (en) | DIHYDROQUINAZOLINES SUBSTITUTE AS ANTIVIRAL AGENTS | |
PE20040907A1 (en) | ANILINOPYRAZOLE DERIVATIVES | |
PE20081504A1 (en) | REPLACED BICYCLOCARBOXIAMIDE COMPOUNDS | |
PE20081496A1 (en) | DERIVATIVES OF 2,5-DIHIDRO-3-H-PIRAZOLO [4,3-C] PIRIDAZIN-3-ONA SUBSTITUTED AS ANTAGONISTS OF CB1 RECEPTORS | |
PE20020692A1 (en) | BENZOTHIOPHENE-DERIVED COMPOUNDS AND ITS OBTAINING PROCEDURE | |
PE106299A1 (en) | DERIVATIVES OF 2- (4-ARIL OR HETEROARIL-PIPERAZIN-1-ILMETIL) -1H-INDOL | |
PE20030541A1 (en) | ALKYNATED FUSED RING PYRIMIDINE COMPOUNDS AS TYPE 13 MATRIX METALOPROTEASE INHIBITORS | |
PE20060584A1 (en) | PYRIDINE DERIVATIVES AS ANTAGONISTS OF CANNABINOID CB1 RECEPTORS AND PREPARATION PROCEDURE | |
PE20030539A1 (en) | PIPERAZINE DERIVATIVES ANTAGONISTS OF SOMATOSTATIN SST1 RECEPTORS | |
AR065180A1 (en) | DERIVADOS DE INDOL - 2 - IL - PIPERAZIN - 1 - IL - METANONA AND PHARMACEUTICAL COMPOSITION | |
PE20001461A1 (en) | COMPOUNDS DERIVED FROM 3,16-DIHIDROXI-ESTRA-1,3,5 (10) -TRIENO, USE OF THE SAME AND OF STRUCTURAL PARTS OF THE SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
PE20081833A1 (en) | SPIRO-PIPERIDINE DERIVATIVES |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant, registration | ||
FD | Application declared void or lapsed |